Evaluation of Novel Therapeutic Approaches in Chronic Lymphocytic Leukaemia to Eradicate Resistant Subclones with DNA Damage Response Defects

Project Details

Short titleEvaluation of Novel Therapeutic Approaches in Chronic Lymphocytic Leukaemia to Eradicate Resistant Subclones with DNA Damage Response Defects
StatusFinished
Effective start/end date5/08/144/08/17

Funding

  • BLOODWISE